Novartis AGNVSNYSE
Loading
Total Costs & Expenses Over TimeStable
Percentile Rank43
3Y CAGR+2.0%
5Y CAGR-1.0%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+2.0%/yr
vs -1.5%/yr prior
5Y CAGR
-1.0%/yr
Recent acceleration
Acceleration
+3.5pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
4 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $37.74B | +1.5% |
| 2024 | $37.18B | +0.8% |
| 2023 | $36.89B | +3.9% |
| 2022 | $35.52B | +4.7% |
| 2021 | $33.92B | -14.7% |
| 2020 | $39.75B | +0.4% |
| 2019 | $39.59B | +5.0% |
| 2018 | $37.70B | +8.6% |
| 2017 | $34.70B | -15.7% |
| 2016 | $41.17B | - |